Quiz: The Phase 3 ALESIA Study for ALK-Positive Non-Small Cell Lung Cancer
In our lung cancer quiz, you’ll get to test your knowledge on the phase 3 ALESIA study.
ALESIA was a randomized, open-label, phase 3 study of alectinib (Alecensa) at 21 investigational sites in China, South Korea, and Thailand. Which pivotal phase 3 trial leading to approval of the agent in the United States does ALESIA most closely resemble?
a. PROFILE 1014 trial
b. ALEX trial
c. AF-001JP study
d. Study B7461001
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Related Content
